Carisma Therapeutics News

CARISMA Therapeutics Analyst Ratings

BenzingaNov 19 05:44

Carisma Therapeutics Price Target Maintained With a $24.00/Share by D. Boral Capital

Dow JonesNov 12 06:21

Carisma Therapeutics Is Maintained at Buy by D. Boral Capital

Dow JonesNov 12 06:21

Optimistic Buy Rating for Carisma Therapeutics Amid Promising CAR-Myeloid Developments and Strong Financial Standing

TipRanksNov 11 14:16

Evercore Maintains Carisma Therapeutics(CARM.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 8 22:38

Evercore ISI Remains a Buy on Carisma Therapeutics (CARM)

TipRanksNov 8 22:20

CARISMA Therapeutics Analyst Ratings

BenzingaNov 7 21:33

EF Hutton Maintains Buy on CARISMA Therapeutics, Maintains $24 Price Target

BenzingaNov 7 21:33

EF Hutton Initiates Coverage On CARISMA Therapeutics With Buy Rating, Announces Price Target of $24

BenzingaOct 30 21:16

CARISMA Therapeutics Analyst Ratings

BenzingaOct 30 21:15

Buy Rating for Carisma Therapeutics Amid Expansion Into Autoimmune Treatments With Moderna Collaboration

TipRanksSep 13 14:09

Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)

TipRanksAug 14 00:38

Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), 4D Molecular Therapeutics (FDMT) and Carisma Therapeutics (CARM)

TipRanksAug 9 19:45

HC Wainwright & Co. Reiterates Buy on CARISMA Therapeutics, Maintains $8 Price Target

BenzingaJun 28 19:24

HC Wainwright & Co. Reiterates Buy on CARISMA Therapeutics, Maintains $8 Price Target

BenzingaJun 27 00:22

CARISMA Therapeutics Analyst Ratings

BenzingaJun 27 00:22

CARISMA Therapeutics Analyst Ratings

BenzingaMay 17 22:30

HC Wainwright & Co. Reiterates Buy on CARISMA Therapeutics, Maintains $8 Price Target

BenzingaMay 17 22:30

Buy Rating Affirmed for Carisma Therapeutics Amid Progress in CAR-Monocyte Cancer Therapy

TipRanksMay 17 18:25

Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)

TipRanksMay 14 19:45